EUVIMEDEUVIMED entdecken
Open Access

Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis

Lorenz H Lehmann iD, Markus B Heckmann iD, Guillaume Bailly, Daniel Finke iD, Adrien Procureur iD, John R Power iD, Frederic Stein, Marie Bretagne, Stephane Ederhy iD, Charlotte Fenioux, Omar Hamwy, Elisa Funck-Brentano iD und 15 weitere

Circulation · 08.08.2023 · 148 (6) · 473-486

DOI: 10.1161/circulationaha.123.062405 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 08.08.2023. Verfasst von Lorenz H Lehmann und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Angiology, and Pneumology, Heidelberg University Hospital, German Centre for Cardiovascular Research DZHK, Heidelberg, Germ…. Hauptthemen laut MEDLINE: Myocarditis. Die Arbeit wurde bisher 172-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Immune checkpoint inhibitors (ICIs) are approved for multiple cancers but can result in ICI-associated myocarditis, an infrequent but life-threatening condition. Elevations in cardiac biomarkers, specifically troponin-I (cTnI), troponin-T (cTnT), and creatine kinase (CK), are used for diagnosis. However, the association between temporal elevations of these biomarkers with disease trajectory and outcomes has not been established. METHODS: We analyzed the diagnostic accuracy and prognostic performances of cTnI, cTnT, and CK in patients with ICI myocarditis (n=60) through 1-year follow-up in 2 cardio-oncology units (APHP Sorbonne, Paris, France and Heidelberg, Germany). A total of 1751 (1 cTnT assay type), 920 (4 cTnI assay types), and 1191 CK sampling time points were available. Major adverse cardiomyotoxic events (MACE) were defined as heart failure, ventricular arrhythmia, atrioventricular or sinus block requiring pacemaker, respiratory muscle failure requiring mechanical ventilation, and sudden cardiac death. Diagnostic performance of cTnI and cTnT was also assessed in an international ICI myocarditis registry. RESULTS: Within 72 hours of admission, cTnT, cTnI, and CK were increased compared with upper reference limits (URLs) in 56 of 57 (98%), 37 of 42 ([88%] P =0.03 versus cTnT), and 43 of 57 ([75%] P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyocarditisHumansImmune Checkpoint InhibitorsBiomarkersCreatine KinasePrognosisTroponin T

Stichwörter der Autor:innen

biomarkersdrug-related side effects and adverse reactionsimmune checkpoint inhibitorsmyocarditispharmacologytroponins

Substanzen

Immune Checkpoint InhibitorsBiomarkersCreatine KinaseTroponin T

Autor:innen und Institutionen

  • Department of Cardiology, Angiology, and Pneumology, Heidelberg University Hospital, German Centre for Cardiovascular Research DZHK, Heidelberg, Germany (L.H.L., M.B.H., D.F., F.S., J.P.M., H.A.K., E.G., N.F., Z.K.).
  • German Cancer Research Center (DKFZ), Heidelberg, Germany (L.H.L.).
  • Sorbonne Université, Assistance Publique-Hôpitaux de Paris, INSERM, Department of Pharmacology, UNICO-GRECO Cardio-oncology program, Pitié-salpétrière Hospital, Paris, France (G.B., A.P., F.S., M.B., C.F., O.H., J-E.S.).
  • University of California San Diego (J.R.P).
  • Sorbonne Université, Assistance Publique-Hôpitaux de Paris, INSERM, Department of Cardiology, UNICO-GRECO Cardio-oncology program, Saint-Antoine Hospital, Paris, France (S.E.).
  • Hopital Ambroise-Paré, Neuilly Sur Seine, France (E.F-B.).

ORCID-Profile: Lorenz H Lehmann, Markus B Heckmann, Daniel Finke, Adrien Procureur, John R Power, Stephane Ederhy, Elisa Funck-Brentano, Laurence Pieroni, Jan P Münster, Yves Allenbach, Nicolas L Palaskas, Salim S Hayek, Evangelos Giannitsis, Ziya Kaya, Javid Moslehi, Edi Prifti, Joe-Elie Salem

Förderung

  • NCI NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Lehmann, L. H., Heckmann, M. B., Bailly, G., Finke, D., Procureur, A., Power, J. R., Stein, F., Bretagne, M., Ederhy, S., Fenioux, C., Hamwy, O., Funck-Brentano, E., Romano, E., Pieroni, L., Münster, J. P., Allenbach, Y., Anquetil, C., Leonard-Louis, S., Palaskas, N. L., …, & Salem, J. E. (2023). Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis. Circulation, 148(6), 473-486. https://doi.org/10.1161/circulationaha.123.062405

Vancouver

Lehmann LH, Heckmann MB, Bailly G, Finke D, Procureur A, Power JR, et al. Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis. Circulation. 2023;148(6):473-486. doi:10.1161/circulationaha.123.062405

BibTeX
@article{Lehmann2023,
  author = {Lehmann, Lorenz H and Heckmann, Markus B and Bailly, Guillaume and Finke, Daniel and Procureur, Adrien and Power, John R and Stein, Frederic and Bretagne, Marie and Ederhy, Stephane and Fenioux, Charlotte and Hamwy, Omar and Funck-Brentano, Elisa and Romano, Emanuela and Pieroni, Laurence and Münster, Jan P and Allenbach, Yves and Anquetil, Céline and Leonard-Louis, Sarah and Palaskas, Nicolas L and Hayek, Salim S and Katus, Hugo A and Giannitsis, Evangelos and Frey, Norbert and Kaya, Ziya and Moslehi, Javid and Prifti, Edi and Salem, Joe-Elie},
  title = {Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis},
  journal = {Circulation},
  year = {2023},
  volume = {148},
  number = {6},
  pages = {473--486},
  doi = {10.1161/circulationaha.123.062405}
}
Kostenlos starten →